Showing results (961-970 of 1,047) with videos related to

Sort By:
Pageof 105
Journal of Vitreoretinal Diseases|November 6, 2023
Retinal Detachment Associated With Giant Retinal Tears: Surgical Management and Outcomes in the Past 2 DecadesJosé Antonio San Martín Varela, Manuel Andrés Gallegos Morales, Juan Ignacio Verdaguer Díaz, et al.
Molecular and Cellular Biology|August 15, 2003
Of mice and MEN1: Insulinomas in a conditional mouse knockoutJudy S Crabtree, Peter C Scacheri, Jerrold M Ward, et al.
Gastroenterology|October 13, 2006
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumorsJens K Habermann, Uwe J Roblick, Brian T Luke, et al.
Oncogene|October 2, 2019
Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1Yuan Xu, Deborah R Surman, Laurence Diggs, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
BMJ Open|November 19, 2021
Protective potential of high-intensity interval training on cardiac structure and function after COVID-19: protocol and statistical analysis plan for an investigator-blinded randomised controlled trialIben Elmerdahl Rasmussen, Frederik Foged, Josephine Bjørn Budde, et al.
International Journal of Obesity (2005)|June 5, 2020
Birth weight, cardiometabolic risk factors and effect modification of physical activity in children and adolescents: pooled data from 12 international studiesGuro Pauck Bernhardsen, Trine Stensrud, Bjørge Herman Hansen, et al.
Epilepsia|October 25, 2000
Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countriesD C Heaney, S D Shorvon, J W Sander, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
International Journal of Cancer|July 24, 2012
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinomaNaotake Funamizu, Chaoxin Hu, Curtis Lacy, et al.
Pageof 105